Mattia Altini

Mattia Altini

Auto-generated profile, based on publicly available information

Mattia Altini

Healthcare Administration, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2022 in Pharmacoepidemiology and Drug Safety
Verified
Journal Article
Closed access
IKIva Selke Krulichová
Iva Selke Krulichová
GSGisbert W. Selke
Gisbert W. Selke
MBMarion Bennie Marion Bennie
Marion Bennie Marion Bennie
MHMohammadhossein Hajiebrahimi
Mohammadhossein Hajiebrahimi
FNFredrik Nyberg
Fredrik Nyberg
BWBjörn Wettermark
Björn Wettermark

8 August 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
MPMichela Palelschi
Michela Palelschi
RMROBERTA MALTONI
ROBERTA MALTONI
SRSara Ravaioli
Sara Ravaioli
AVAlessandro Vagheggini
Alessandro Vagheggini
FMFrancesca Mannozzi
Francesca Mannozzi
SBSara Bravaccini
Sara Bravaccini
CDK4/6 inhibitors (CDK4/6i) are recommended in patients with estrogen receptor (ER)-positive, HER2-negative advanced breast cancer (ABC). Up to now, no prognostic biomarkers have been identified in this setting. We retrospectively analyzed the expression of progesterone receptor (PR) and Ki67, assessed by immunohistochemistry, in 71 ABC patients treated with CDK4/6i and analyzed the impact of these markers on progression-free survival (PFS). The majority of patients 63/71 (88.7%) received palbociclib, 4 (5.6%) received ribociclib, and 4 (5.6%) received abemaciclib. A higher median value of Ki67 was observed in cases undergoing second-line treatment (p = 0.047), whereas the luminal B subtype was more prevalent (p = 0.005). In the univariate analysis of the first-line setting, luminal A subtype showed a trend towards a correlation with a longer PFS (p = 0.053). A higher continuous Ki67 value led to a significantly shorter PFS. When the interaction between pathological characteristics and line of treatment was considered, luminal B subtype showed a significantly (p = 0.043) worse outcome (Hazard Ratio (HR) 2.84; 1.03–7.82 95% Confidence Interval (CI)). PFS in patients undergoing endocrine therapy plus CDK4/6i was inversely correlated with Ki67 expression but not with PR, suggesting that tumor proliferation has a greater impact on cell cycle inhibitors combined with endocrine therapy than PR expression.

8 September 2021 in Acta Diabetologica
Verified
Journal Article
Open access
PDF file
RMRossella Messina
Rossella Messina
MIMarica Iommi
Marica Iommi
PRPaola Rucci
Paola Rucci
CRChiara Reno
Chiara Reno
MFMaria Pia Fantini
Maria Pia Fantini
PBPaolo Di Bartolo
Paolo Di Bartolo
Aims: Depression in type 2 diabetes may heavily affect the course of the disease. In this study, we investigated, among new cases with type 2 diabetes, the incidence and clinical predictors of depression and determined the extent to which depression constitutes a risk factor for acute and long-term diabetes complications and mortality. Methods: In this population-based retrospective cohort study, incident cases of type 2 diabetes without a prior history of depression were identified from the administrative databases of the Emilia-Romagna Region, Italy, between 2008 and 2017 and followed up until 2020. Logistic regression models were used to identify the predictors of depression. Cox regression models were used to estimate the risk of acute complications over three years, and the risk of long-term complications and mortality over ten years. Results: Incident cases with type 2 diabetes were 30,815, of whom 5146 (16.7%) developed depression. The predictors of depression onset were as follows: female sex, age > 65 years, living in rural areas and comorbid diseases. Depression in type 2 diabetes was associated with a 2.3-fold risk of developing acute complications, 1.6-fold risk of developing long-term complications and 2.8-fold mortality risk. Conclusions: Our findings highlight that depression is associated with an increased risk for complications in type 2 diabetes and mortality and should not be neglected. Therefore, it is important to promote screening activities and introduce targeted and personalized treatment for depression in order to reduce the risk of poor short- and long-term outcomes of diabetes.

6 October 2021 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
LBLucia Bertoni
Lucia Bertoni
ARAndrea Roncadori
Andrea Roncadori
NGNicola Gentili
Nicola Gentili
Valentina DanesiValentina Danesi
Valentina Danesi
IMIlaria Massa
Ilaria Massa
MMMaria Teresa Montella
Maria Teresa Montella
A retrospective study was conducted among Italian cancer healthcare workers (HCWs) to describe how influenza vaccination attitudes have changed during the COVID-19 pandemic. The analysis was conducted on the last three influenza seasons (2018/19, 2019/20 and 2020/21). To account for different relationships and proximity with patients, the study population was grouped into three main professional categories: health personnel, administrative staff and technicians. Moreover, to explore the factors affecting the coverage of influenza vaccine, a multinomial regression analysis was performed.Over the years, the influenza vaccination uptake showed a gradual increase across the overall staff, the highest coverage (53.8%) was observed in the season 2020/21, in particular, for health personnel (57.7%). In general, males resulted in more adherent to vaccination campaigns; nevertheless, this gap decreased in the last season. A total of 28.6% workers were always vaccinated throughout the past three seasons, a remarkable 25.2% (mainly young and females) received for the first time the influenza vaccination in 2020/21.In this dramatic health crisis, the attitudes of HCWs toward flu vaccination have changed. The COVID-19 outbreak increased adherence to flu vaccination, reaching the highest coverage in the campaign 2020/21. However, further efforts should be made to achieve greater vaccination coverage.

1 February 2018 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
IMIlaria Massa
Ilaria Massa
WBWilliam Balzi
William Balzi
MAMattia Altini
Mattia Altini
RBraffaella berte'
raffaella berte'
MBMonica Bosco
Monica Bosco
MMMarco Maltoni
Marco Maltoni
Literature data on the overuse and misuse of diagnostic procedures leading to end-of-life aggressiveness are scarce due to the limited amount of estimated economic waste. This study investigated the potential overuse of diagnostic procedures in a population of end-of-life patients.

2 October 2020 in International Nursing Review
Verified
Journal Article
Open access
PDF file
AZAnita Zeneli
Anita Zeneli
MAM. Altini
M. Altini
MBM. Bragagni
M. Bragagni
Nicola GentiliNicola Gentili
Nicola Gentili
SPS. Prati
S. Prati
SMS. Montalti
S. Montalti
Aim: To describe our response to the COVID‐19 emergency in a cancer centre to enable other nursing organizations to determine which elements could be useful to manage a surge of patients in their own setting.Background: The COVID‐19 pandemic represents one of the most challenging healthcare scenarios faced to date. Managing cancer care in such a complex situation requires a coordinated emergency action plan to guarantee the continuity of cancer treatments for patients by providing healthcare procedures for patients, caregivers and healthcare professionals in a safe environment.Procedures: We describe the main strategies and role of nurses in implementating such procedures.Results: Nurses at our hospital were actively involved in COVID‐19 response defined by the emergency action plan that positively contributed to correct social distancing and to the prevention of the spread of the virus.Implications for nursing and health policies: Lessons learned from the response to phase I of COVID‐19 have several implications for future nursing and health policies in which nurses play an active role through their involvement in the frontline of such events. Key policies include a coordinated emergency action plan permitting duty of care within the context of a pandemic, and care pathway revision. This requires the rapid implementation of strategies and policies for a nursing response to the new care scenarios: personnel redistribution, nursing workflow revision, acquisition of new skills and knowledge, effective communication strategies, infection control policies, risk assessment and surveillance programmes, and continuous supplying of personal protective equipment. Finally, within a pandemic context, clear nursing policies reinforcing the role of nurses as patient and caregiver educators are needed to promote infection prevention behaviour in the general population.